Hotaling Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$3.67M Buy
71,697
+75
+0.1% +$3.6K 1.66% 18
2022
Q3
$3.13M Sell
71,622
-26,711
-27% -$1.3M 1.5% 20
2022
Q2
$5.16M Buy
98,333
+30,246
+44% +$1.54M 2.24% 7
2022
Q1
$3.52M Sell
68,087
-27,717
-29% -$1.44M 1.35% 18
2021
Q4
$5.66M Buy
95,804
+60,231
+169% +$2.98M 1.96% 9
2021
Q3
$1.53M Sell
35,573
-720
-2% -$31.9K 0.64% 57
2021
Q2
$1.42M Buy
36,293
+1,697
+5% +$66K 0.58% 64
2021
Q1
$1.25M Sell
34,596
-439
-1% -$15.6K 0.56% 58
2020
Q4
$1.29M Sell
35,035
-652
-2% -$23.9K 0.6% 57
2020
Q3
$1.24M Buy
35,687
+3,100
+10% +$109K 0.67% 50
2020
Q2
$1.01M Buy
32,587
+3,645
+13% +$124K 0.58% 58
2020
Q1
$896K Buy
28,942
+232
+0.8% +$7.91K 0.67% 53
2019
Q4
$1.07M Buy
28,710
+2,145
+8% +$76.4K 0.61% 59
2019
Q3
$906K Buy
26,565
+11
+0% +$400 0.58% 58
2019
Q2
$1.09M Sell
26,554
-393
-1% -$15.6K 0.7% 55
2019
Q1
$1.09M Buy
26,947
+10,915
+68% +$437K 0.73% 54
2018
Q4
$664K Buy
+16,032
New +$666K 0.54% 64

Other funds holding PFE

Hotaling Investment Management's PFE Position: Q4 2022 in Review

Hotaling Investment Management increased its Pfizer (PFE) stake by 0.1% in Q4 2022, buying an estimated $3.6K and bringing the position to 71,697 shares worth $3.67M. The position accounts for 1.66% of the portfolio, ranked #18.

Hotaling Investment Management first reported a position in PFE in Q4 2018 and has held it in 17 quarters since. The position peaked at $5.66M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Hotaling Investment Management held 71,697 shares of Pfizer worth $3.67M as of Q4 2022.
  • Hotaling Investment Management bought 75 Pfizer shares in Q4 2022, an estimated $3.6K.
  • Pfizer made up 1.66% of Hotaling Investment Management's portfolio in Q4 2022, its #18 holding.
  • Hotaling Investment Management first reported a position in Pfizer in Q4 2018 and has held it in 17 quarters since.
  • Hotaling Investment Management's Pfizer position peaked at $5.66M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.